The results come amid the first earnings season of 2023, where companies like Novartis, GSK, Amgen and Pfizer have already produced their year-end and quarterly financials.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,